Showing results (1961-1970 of 2,022) with videos related to

Sort By:
Pageof 203
The Journal of Biological Chemistry|August 7, 2015
Neil2-null Mice Accumulate Oxidized DNA Bases in the Transcriptionally Active Sequences of the Genome and Are Susceptible to Innate InflammationAnirban Chakraborty, Maki Wakamiya, Tatiana Venkova-Canova, et al.
Peerj|March 16, 2022
Genotypic variation in root architectural traits under contrasting phosphorus levels in Mediterranean and Indian origin lentil genotypesMuraleedhar Aski, Reena Mehra, Gyan Prakash Mishra, et al.
Circulation|March 3, 2010
Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND studyPaul A Gurbel, Kevin P Bliden, Kathleen Butler, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2016
Convolutional networks for fast, energy-efficient neuromorphic computingSteven K Esser, Paul A Merolla, John V Arthur, et al.
BMC Research Notes|July 18, 2018
Cranial neural tube defect after trimethoprim exposureNor Linda Abdullah, Renuka Gunasekaran, Siti Waheeda Mohd-Zin, et al.
Breast Cancer Research and Treatment|March 26, 2018
GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancerRaksha R Bhat, Puja Yadav, Debashish Sahay, et al.
Cancer Cell|October 10, 2018
MYC Interacts with the G9a Histone Methyltransferase to Drive Transcriptional Repression and TumorigenesisWilliam B Tu, Yu-Jia Shiah, Corey Lourenco, et al.
Frontiers in Immunology|May 17, 2021
Defective Interfering Genomes and the Full-Length Viral Genome Trigger RIG-I After Infection With Vesicular Stomatitis Virus in a Replication Dependent MannerAndreas Linder, Viktoria Bothe, Nicolas Linder, et al.
Drug Development and Industrial Pharmacy|January 16, 2025
Docetaxel and niclosamide-loaded nanofiber systems for improved chemo-therapeutic activity and resistance reversal in prostate cancerSaurabh Shah, Paras Famta, Ganesh Vambhurkar, et al.
Frontiers in Oncology|April 15, 2022
Interim Analysis of Impact of Adding Low Dose Pulmonary Radiotherapy to Moderate COVID-19 Pneumonia Patients: IMpaCt-RT StudyPritanjali Singh, Avik Mandal, Dharmendra Singh, et al.
Pageof 203